Prognostic significance of positive circumferential resection margin post neoadjuvant chemotherapy in patients with esophageal or gastro-esophageal junction adenocarcinoma
Authors
Patrao, AnaPapaxoinis, Georgios
Kordatou, Zoe
Weaver, Jamie M
Owen-Holt, Vikki
Alkhaffaf, B
Galloway, S
Mansoor, Was
Affiliation
University of Manchester Division of Cancer Sciences, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2019
Metadata
Show full item recordAbstract
BACKGROUND: The aim of the present study was to assess the prognosis of patients with esophageal or gastroesophageal junction (E/GEJ) adenocarcinoma extending beyond the muscularis propria layer (?ypT3) and positive circumferential resection margin (CRM), post neoadjuvant chemotherapy. METHODS: 177 patients were retrospectively studied. The majority (94.9%) received ECX (epirubicin, cisplatin, capecitabine), and all had clear proximal/distal resection margins. CRM was defined as positive (CRM+) when it was directly infiltrated (infiltrated CRM) or when tumor cells were detected within 1 mm from CRM (close CRM) and as negative (CRM-) when tumor cells were found in a distance > 1 mm from CRM. RESULTS: CRM+ was found in 83 patients (46.9%). Of them, infiltrated CRM was recorded in 36 (20.3%) and close CRM in 47 (26.6%). Adjuvant chemotherapy was administered to 132 patients (74.6%). Lymphovascular invasion and primary site in the lower esophagus were independently associated with higher risk of CRM+. Patients with infiltrated CRM, compared to those with close CRM and those CRM-, had the shortest median time-to-relapse (11.4 vs. 15.6 vs. 22.1 months, respectively, p?=?0.005) and overall survival (18.7 vs. 23.1 vs. 38.8 months, respectively, p = 0.001). However, CRM status was not an independent predictor of poor outcome. Symptomatic isolated locoregional recurrences were rare in both CRM+ and CRM-patients (4/56 [7.1%] vs. 5/52 [9.6%], p?=?0.736), as well as in infiltrated vs. non-infiltrated CRM (CRM- and close CRM) (0/26 [0%] vs. 9/82 [11.0%], p?=?0.110). CONCLUSION: Although CRM status is associated with poor outcome, it does not represent an independent prognostic factor. The status of CRM did not significantly influence the pattern of cancer relapseCitation
Patrao A, Papaxoinis G, Kordatou Z, Weaver J, Owen-Holt V, Alkhaffaf B, et al. Prognostic significance of positive circumferential resection margin post neoadjuvant chemotherapy in patients with esophageal or gastro-esophageal junction adenocarcinoma. Eur J Surg Oncol. 2019;45(3):439-45.Journal
EuropeanJournal of Surgical OncologyDOI
10.1016/j.ejso.2018.10.530PubMed ID
30786962Additional Links
https://dx.doi.org/10.1016/j.ejso.2018.10.530Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ejso.2018.10.530
Scopus Count
Collections
Related articles
- Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
- Authors: Depypere L, Moons J, Lerut T, De Hertogh G, Peters C, Sagaert X, Coosemans W, Van Veer H, Nafteux P
- Issue date: 2018 Feb 1
- The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study.
- Authors: Papaxoinis G, Kamposioras K, Weaver JMJ, Kordatou Z, Stamatopoulou S, Germetaki T, Nasralla M, Owen-Holt V, Anthoney A, Mansoor W
- Issue date: 2019 Sep
- Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
- Authors: Lagarde SM, Phillips AW, Navidi M, Disep B, Griffin SM
- Issue date: 2017 Dec 1
- Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route.
- Authors: Scheepers JJ, van der Peet DL, Veenhof AA, Cuesta MA
- Issue date: 2009
- Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
- Authors: Saha AK, Sutton C, Rotimi O, Dexter S, Sue-Ling H, Sarela AI
- Issue date: 2009 May